bibliographic resource 408804 [br/408804]
https://w3id.org/oc/corpus/br/408804

is a
title
  • Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
publication date
  • 2015-01-01
contributor
format
identifier
part of